Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -35,478 | -28,323 | -19,931 | -7,420 | -31,476 |
| Depreciation Amortization | -119 | 27 | 8 | 9 | 9 |
| Accounts payable and accrued liabilities | 3,021 | 3,735 | 3,851 | 261 | 271 |
| Other Working Capital | 1,757 | 5,162 | 5,713 | -55 | -392 |
| Other Operating Activity | 74 | -1,337 | -2,244 | 538 | 2,882 |
| Operating Cash Flow | $-30,745 | $-20,736 | $-12,603 | $-6,667 | $-28,706 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -35,956 | N/A | N/A | N/A | 135 |
| PPE Investments | -37 | -6 | -6 | -6 | -88 |
| Investing Cash Flow | $-35,993 | $-6 | $-6 | $-6 | $47 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 53,014 | 14 | 8 | 8 | 25,016 |
| Other Financing Activity | -1,157 | -34 | -26 | -16 | -332 |
| Financing Cash Flow | $51,857 | $-20 | $-18 | $-8 | $24,684 |
| Beginning Cash Position | 37,125 | 37,125 | 37,125 | 37,125 | 41,100 |
| End Cash Position | 22,244 | 16,363 | 24,498 | 30,444 | 37,125 |
| Net Cash Flow | $-14,881 | $-20,762 | $-12,627 | $-6,681 | $-3,975 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,745 | -20,736 | -12,603 | -6,667 | -28,706 |
| Capital Expenditure | -37 | -6 | -6 | -6 | -88 |
| Free Cash Flow | -30,782 | -20,742 | -12,609 | -6,673 | -28,794 |